Ramipril

Link to article at PubMed

2023 Aug 17. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–.

ABSTRACT

Ramipril is an angiotensin-converting enzyme (ACE) inhibitor and is utilized for multiple indications, including hypertension and prevention of heart failure progression following a myocardial infarction (MI). Ramipril is also used to reduce the risk of MI, stroke, and mortality in patients older than 55 with a high risk of atherosclerotic disease and major adverse cardiac events. This activity provides a comprehensive review of Ramipril's indications, mechanism of action, methods of administration, significant adverse effects, contraindications, and monitoring. This activity aims to assist interprofessional team members in effectively managing hypertension and cardiovascular disease.

PMID:30725804 | Bookshelf:NBK537119

Leave a Reply

Your email address will not be published. Required fields are marked *